Showing results (11-20 of 219) with videos related to
Sort By:
Pageof 22
American Journal of Pharmaceutical Education|February 21, 2012
Transitioning knowledge gained from simulation to pharmacy practiceSandra L Kane-Gill, Pamela L SmithburgerThe Annals of Pharmacotherapy|September 16, 2004
Sedation assessment in critically ill adults: 2001-2004 updateBrian D Watson, Sandra L Kane-GillThe Annals of Pharmacotherapy|July 20, 2006
Adverse drug event reporting in intensive care units: a survey of current practicesSandra L Kane-Gill, John W DevlinCritical Care Clinics|September 28, 2015
Drug-Induced Acute Kidney Injury: A Focus on Risk Assessment for PreventionSandra L Kane-Gill, Stuart L GoldsteinAntibiotics (Basel, Switzerland)|November 27, 2025
Anti-Infective-Associated AKI: A Narrative Review of the Epidemiology, Mechanisms, Risk Factors, Biomarkers, Clinical Course, Monitoring, Prevention, and Therapeutic StrategiesIman Karimzadeh, Sandra L Kane-Gill, Binglei MaCurrent Opinion in Critical Care|October 7, 2020
Biomarker-guided management of acute kidney injurySandra L Kane-Gill, Melanie Meersch, Max BellResearch in Social & Administrative Pharmacy : RSAP|November 5, 2017
Impact of clinical pharmacist services delivered via telemedicine in the outpatient or ambulatory care setting: A systematic reviewJoshua D Niznik, Harvey He, Sandra L Kane-GillThe Annals of Pharmacotherapy|October 6, 2005
Are the Naranjo criteria reliable and valid for determination of adverse drug reactions in the intensive care unit?Sandra L Kane-Gill, Levent Kirisci, Dev S PathakHealth Systems (Basingstoke, England)|July 11, 2026
The combined use of natural language processing and electronic health records data to identify historical tolerances of β-lactams and promote clinician confidence in future useMatthew Gray, Richard D Boyce, Sandra L Kane-GillCritical Care Medicine|May 27, 2010
Adverse drug events in intensive care units: risk factors, impact, and the role of team careSandra L Kane-Gill, Judith Jacobi, Jeffrey M RothschildPageof 22